148 related articles for article (PubMed ID: 36610075)
21. A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Pozzi L; Schmidli H; Ohlssen DI
Pharm Stat; 2016 Jul; 15(4):341-8. PubMed ID: 27061897
[TBL] [Abstract][Full Text] [Related]
22. Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.
Weir CJ; Taylor RS
Pharm Stat; 2022 Jul; 21(4):740-756. PubMed ID: 35819121
[TBL] [Abstract][Full Text] [Related]
23. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).
Lassere MN; Johnson KR; Schiff M; Rees D
BMC Med Res Methodol; 2012 Mar; 12():27. PubMed ID: 22409774
[TBL] [Abstract][Full Text] [Related]
24. A maximum entropy approach for the evaluation of surrogate endpoints based on causal inference.
Alonso A; Van der Elst W; Molenberghs G
Stat Med; 2018 Dec; 37(29):4525-4538. PubMed ID: 30141219
[TBL] [Abstract][Full Text] [Related]
25. Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm.
Roberts EK; Elliott MR; Taylor JMG
Stat Med; 2021 Dec; 40(29):6605-6618. PubMed ID: 34528260
[TBL] [Abstract][Full Text] [Related]
26. Bayesian semiparametric mixed effects models for meta-analysis of the literature data : An application to cadmium toxicity studies.
Jo S; Park B; Chung Y; Kim J; Lee E; Lee J; Choi T
Stat Med; 2021 Jul; 40(16):3762-3778. PubMed ID: 33906261
[TBL] [Abstract][Full Text] [Related]
27. Solutions for surrogacy validation with longitudinal outcomes for a gene therapy.
Roberts EK; Elliott MR; Taylor JMG
Biometrics; 2023 Sep; 79(3):1840-1852. PubMed ID: 35833874
[TBL] [Abstract][Full Text] [Related]
28. Statistical evaluation of surrogate endpoints with examples from cancer clinical trials.
Buyse M; Molenberghs G; Paoletti X; Oba K; Alonso A; Van der Elst W; Burzykowski T
Biom J; 2016 Jan; 58(1):104-32. PubMed ID: 25682941
[TBL] [Abstract][Full Text] [Related]
29. Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer.
Korn EL; Sachs MC; McShane LM
Ann Oncol; 2016 Jan; 27(1):10-5. PubMed ID: 26489443
[TBL] [Abstract][Full Text] [Related]
30. A bayesian approach to surrogacy assessment using principal stratification in clinical trials.
Li Y; Taylor JM; Elliott MR
Biometrics; 2010 Jun; 66(2):523-31. PubMed ID: 19673864
[TBL] [Abstract][Full Text] [Related]
31. A Bayesian semiparametric joint hierarchical model for longitudinal and survival data.
Brown ER; Ibrahim JG
Biometrics; 2003 Jun; 59(2):221-8. PubMed ID: 12926706
[TBL] [Abstract][Full Text] [Related]
32. Bayesian hierarchical functional data analysis via contaminated informative priors.
Scarpa B; Dunson DB
Biometrics; 2009 Sep; 65(3):772-80. PubMed ID: 19173703
[TBL] [Abstract][Full Text] [Related]
33. How to use frailtypack for validating failure-time surrogate endpoints using individual patient data from meta-analyses of randomized controlled trials.
Sofeu CL; Rondeau V
PLoS One; 2020; 15(1):e0228098. PubMed ID: 31990928
[TBL] [Abstract][Full Text] [Related]
34. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
Jiang Z; Song Y; Shou Q; Xia J; Wang W
Trials; 2014 Dec; 15():500. PubMed ID: 25528466
[TBL] [Abstract][Full Text] [Related]
35. Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity.
Guo X; Bourgeois FT; Cai T
Stat Methods Med Res; 2024 May; ():9622802241247719. PubMed ID: 38717356
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis for the evaluation of potential surrogate markers.
Daniels MJ; Hughes MD
Stat Med; 1997 Sep; 16(17):1965-82. PubMed ID: 9304767
[TBL] [Abstract][Full Text] [Related]
37. Surrogate mothers 10 years on: a longitudinal study of psychological well-being and relationships with the parents and child.
Jadva V; Imrie S; Golombok S
Hum Reprod; 2015 Feb; 30(2):373-9. PubMed ID: 25527614
[TBL] [Abstract][Full Text] [Related]
38. Semiparametric bayesian analysis of nutritional epidemiology data in the presence of measurement error.
Sinha S; Mallick BK; Kipnis V; Carroll RJ
Biometrics; 2010 Jun; 66(2):444-54. PubMed ID: 19673858
[TBL] [Abstract][Full Text] [Related]
39. Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy.
Fouarge E; Monseur A; Boulanger B; Annoussamy M; Seferian AM; De Lucia S; Lilien C; Thielemans L; Paradis K; Cowling BS; Freitag C; Carlin BP; Servais L;
Orphanet J Rare Dis; 2021 Jan; 16(1):3. PubMed ID: 33407688
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
